TNF-α levels and TNF-α gene polymorphism in type I Gaucher disease
TNF-α levels and TNF-α gene polymorphism in type I Gaucher disease
复制标题
DOI:
10.1016/j.cyto.2005.03.006
复制
发表时间:
2005-07-21
期刊:
影响因子:
3.8
通讯作者:
Elstein, D
中科院分区:
文献类型:
--
作者:
Altarescu, G;Zimran, A;Elstein, D
The objective of this pilot study was to determine the levels of Tumor Necrosis Factor (TNF)-alpha and TNF-alpha gene polymorphism as a marker of inflammation among patients with type I Gaucher disease as well as to ascertain the relationship between this cytokine and parameters of disease severity and other measures of inflammation. Levels of TNF-alpha and genotyping for the -308 G -> A polymorphism in the promoter of the TNF-alpha gene were performed in 17 patients with type I Gaucher disease. TNF-alpha levels were compared with the promoter gene polymorphism, and with hematological and other clinical parameters of Gaucher disease. Eight patients (47.1 %)were homozygotes (A/A) for the TNF-alpha polymorphism, six patients (35.3%) had the wild type(G/G),and three patients (17.6%) were heterozygotes (G/A). A significant correlation was found between serum TNF-alpha levels and TNF-alpha genotypes for homozygotes versus heterozygotes patients (p = 0.02), with patients homozygous for the polymorphism having the lower levels of serum TNF-alpha relative to heterozygotes with the highest levels. No correlation was found between TNF-alpha genotypes and chitotriosidase levels, a putative biochemical marker for Gaucher disease severity. Because a significant correlation was found between homozygosity for a common promoter polymorphism of TNF-alpha and milder expression i.e. non-neuronopathic form, of Gaucher disease (versus the neuronopathic forms), this may be Suggestive of an association between genetic variability in TNF-alpha and phenotypic expression in Gaucher disease. Larger studies will be required. (c) 2005 Elsevier Ltd. All rights reserved.